606
Participants
Start Date
August 31, 2009
Primary Completion Date
April 30, 2012
Study Completion Date
August 31, 2012
telbivudine
telbivudine, 600mg, oral, daily
telbivudine
telbivudine, 600mg, oral, daily
302 Military Hospital of China, Beijing
Beijing Ditan Hospita, Beijing
Beijing Friendship Hospital Attached to the Capital Medical University, Beijing
BeiJing YouAn Hospital ,Capital Medical University, Beijing
Department of infectious disease, First Hospital of Peking University, Beijing
People'S Hospital Under Beijnig University, Beijing
The Second Affiliated of ChongQing University of Medical Science, Chongqing
Department of infectious disease, Nanfang Hospital, Guangzhou
No. 8 People's Hospital In GuangZhou, Guangzhou
The Third Hospital of Sun Yat-Sen University, Guangzhou
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Xiangya Hospital Central-South Univrsity, Changsha
No.81 Hospital of PLA, Nanjing
First Hospital .Jilin Unniversity, Changchun
ShengJing Hospital of China Medical University, Shenyang
JiNan Infectious Diseases Hospital, Jinan
Changhai Hospital affiliated to Second Military Medical University, Shanghai
Huashan Hospital，Fudan University, Shanghai
No.85 Hospital of PLA, Shanghai
Shanghai Ruijin Hospital, Shanghai
Tangdu Hospital, XiAn
West China Hospital.SiChuan University, Chengdu
The First Affiliated Hospital of College of Medicine ，Zhejiang University, Hangzhou
The Sixth People's Hospital of Hangzhou, Hangzhou
Collaborators (1)
Major Science and Technology Special Project of China Eleventh Five-year
OTHER
Novartis
INDUSTRY
Nanfang Hospital, Southern Medical University
OTHER